Session 2 & 4: Antimicrobial drug discovery
Monday 3 April & Tuesday 4 April
Chairs: Dr Mark Blaskovich and Professor Matthew Cooper
New antibiotics are desperately needed to treat drug-resistant bacterial infections – with novel chemotypes acting on novel targets a rare commodity.
This session will examine early discovery research that could lead to the first next new class of antibiotics in decades.
- Professor Gerry Wright, Michael G. DeGroote Institute for Infectious Disease Research, Canada
- Professor Elizabeth Winzeler, University of California, USA
- Dr Didier Leroy, Medicines for Malaria Venture
- Dr Jennifer Leeds, Head of Antibacterial Discovery, Novartis
- Dr Terry Roemer, Head of Antimicrobial Discovery, Merck, USA
- Dr Michelle Wykes, QIMR Berghofer Medical Research Institute
- Professor Joe Pogliano, University of California, San Diego
- Dr Qin Cheng, Australian Army Malaria Institute
|
